Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection
An up-to-date assessment of US prostate cancer incidence rates by stage and race: A novel approach combining multiple imputation with age and delay adjustment
Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging collaboration for cancer of the prostate